Intellectual Property

The Company is developing an intellectual property position based on trades secrets, trademarks, and patent applications seeking composition of matter, pharmaceutical formulation and methods of use for:

  • Tau oligomer target
  • Proteolytic activity of tau oligomers including
    • screening assay
    • antibodies
  • Composition of matter and synthetic route for small molecule inhibitors and antibodies specific for tau oligomers